Australia markets close in 52 minutes
Explore/

Most removed from watchlists

Most removed from watchlists

4.49k followers28 symbols Watchlist by Yahoo Finance

Follow this list to discover and track stocks that were removed from most watchlists by Yahoo Finance users. This list is generated daily and limited to the top 30 stocks that meet the criteria.

Curated by Yahoo Finance

Follow this list to discover and track stocks that were removed from most watchlists by Yahoo Finance users. This list is generated daily and limited to the top 30 stocks that meet the criteria.

Background

Yahoo Finance employs sophisticated algorithms to monitor and detect trends in the Global Financial Markets. We bring these insights to you in the form of watchlists.

Find other winning investment ideas with the Yahoo Finance Screener.

How are these weighted?

The stocks in this watchlist are weighted equally.

Performance

WatchlistChange today1-month return1-year returnTotal return
Most removed from watchlists----
^GSPC+0.03%+0.47%+26.52%+5958.69%

28 symbols

SymbolCompany nameLast priceChange% changeMarket timeVolumeAvg vol (3-month)Market cap
  • Yahoo Finance

    Why big banks are obsessed with 1995

    Can 1995 happen again for the big banks? It might be a moonshot scenario for 2025 as the Fed contemplates rate cuts.

  • Yahoo Finance Video

    Dell, Mobileye, HPE: 3 Stocks In Focus

    Morning Brief Hosts Seana Smith and Brad Smith break down some of Tuesday's trending tickers on the Yahoo Finance platform Mizuho Securities has initiated coverage of Dell Technologies (DELL), giving it an Outperform rating and a price target of $135, citing the growth of its generative AI. Shares of Mobileye Global (MBLY) are trading higher after being excluded from Intel's (INTC) updates about the chip company's "next phase of transformation." This comes after Bloomberg reported that Intel was considering options for its 88% stake in Mobileye. Finally, Bank of America has upgraded Hewlett Packard Enterprise (HPE) stock to a Buy rating and lifted its price target to $24 per share from $21, citing cost-cutting measures and its upcoming acquisition of Juniper Networks (JNPR). For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Melanie Riehl

  • The Accountant

    Pfizer and AstraZeneca debate: when “the greater good” matters

    Pfizer and AstraZeneca Debate: When “the Greater Good” Matters The business pages, and now the mainstream media, have been dominated over the last week with news of Pfizer’s proposed $106bn takeover of AstraZeneca, which would make it the largest ever foreign takeover of a UK company. Now, a number of politicians have become involved and…